Verition Fund Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,422
Closed -$546K 3641
2024
Q4
$546K Buy
+39,422
New +$622K ﹤0.01% 2428
2024
Q3
Sell
-15,757
Closed -$325K 3455
2024
Q2
$325K Buy
+15,757
New +$341K ﹤0.01% 2295
2022
Q1
Sell
-35,878
Closed -$1.77M 2967
2021
Q4
$1.77M Buy
+35,878
New +$1.99M 0.01% 962
2020
Q4
Sell
-17,109
Closed -$171K 1338
2020
Q3
$171K Sell
17,109
-86,825
-84% -$1.04M ﹤0.01% 957
2020
Q2
$1.09M Buy
103,934
+23,955
+30% +$266K 0.04% 391
2020
Q1
$856K Buy
79,979
+9,330
+13% +$113K 0.03% 253
2019
Q4
$1.12M Sell
70,649
-87,535
-55% -$939K 0.02% 421
2019
Q3
$1.24M Buy
+158,184
New +$1.41M 0.03% 364

Other funds holding PRTA

Verition Fund Management's PRTA Position: Q1 2025 in Review

Verition Fund Management sold out of Prothena Corp (PRTA) in Q1 2025, closing a stake of 39,422 shares — an estimated $546K sold.

Verition Fund Management first reported a position in PRTA in Q3 2019 and held it in 8 quarters. The position peaked at $1.77M in Q4 2021. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.

  • Verition Fund Management reported no remaining Prothena Corp position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 39,422 Prothena Corp shares in Q1 2025, an estimated $546K.
  • Verition Fund Management first reported a position in Prothena Corp in Q3 2019 and held it in 8 quarters.
  • Verition Fund Management's Prothena Corp position peaked at $1.77M in Q4 2021.
  • 161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.